Trials / Completed
CompletedNCT07027878
JETi Lower Extremity Venous Thrombosis
JETi Enhanced Thrombectomy Intervention Registry - JETi Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 121 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The JETi Registry is a prospective, single-arm, multicenter study to collect real-world data on the safety, performance, and clinical benefits of the JETi System for the treatment of acute and subacute thrombosis in the peripheral vasculature. This is a post-market study that will register approximately 280 subjects at approximately 30 centers globally. Subjects participating in this registry will be followed through their 12-month follow up visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JETi lower extremity venous thrombosis | The JETi System is a hydro-mechanical aspiration system, intended for the removal of intravascular thrombus. The system comprises of the JETi Catheter (6F or 8F), JETi Pump Set, JETi Saline Drive Unit (SDU), JETi Accessory Cart, JETi Suction tubing and JETi Non-Sterile Canister Set. The JETi System is designed to continuously aspirate thrombotic material into the catheter, where a high-pressure stream of saline within the catheter tip macerates the thrombus as it is aspirated. |
Timeline
- Start date
- 2020-08-03
- Primary completion
- 2024-08-01
- Completion
- 2025-07-16
- First posted
- 2025-06-19
- Last updated
- 2026-04-03
- Results posted
- 2026-04-03
Locations
30 sites across 4 countries: United States, Australia, Canada, Germany
Source: ClinicalTrials.gov record NCT07027878. Inclusion in this directory is not an endorsement.